Targeting autophagy to sensitive glioma to temozolomide treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting autophagy to sensitive glioma to temozolomide treatment

Published:2016-02-02 Issue:1 Volume:35 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Yan Yuanliang,Xu Zhijie,Dai Shuang,Qian Long,Sun Lunquan,Gong Zhicheng

Funder

National Natural Science Foundation of China

Changsha Science and Technology Project

Clinical and Rehabilitation Research Foundation of Xiangya hospital - Beidaweiming

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-016-0303-5

Reference122 articles.

1. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 2010;10:319–31.

2. Knisely JP, Baehring JM. A silver lining on the horizon for glioblastoma. Lancet Oncol. 2009;10:434–5.

3. Nanegrungsunk D, Onchan W, Chattipakorn N, Chattipakorn SC. Current evidence of temozolomide and bevacizumab in treatment of gliomas. Neurol Res. 2015;37:167–83.

4. Messaoudi K, Clavreul A, Lagarce F. Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide. Drug Discov Today. 2015;20:899–905.

5. Wait SD, Prabhu RS, Burri SH, Atkins TG, Asher AL. Polymeric drug delivery for the treatment of glioblastoma. Neuro Oncol. 2015;17 Suppl 2:ii9–ii23.

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs);Journal of Translational Medicine;2024-09-10

2. Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy;Current Cancer Drug Targets;2024-09

3. Regulatory effects of statins on Akt signaling for prevention of cancers;Cellular Signalling;2024-08

4. Immunomodulatory signalling networks in glioblastoma multiforme: a comprehensive review of therapeutic approaches;Human Cell;2024-07-31

5. Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment;Frontiers in Pharmacology;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3